The United States government will pay Johnson & Johnson over US$1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
US to pay US$1 billion for 100 million doses of J&J’s COVID-19 vaccine candidate
